NCT03185754 is a NA clinical trial of Sublobar resection in Lung Cancer, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT03185754?

NCT03185754 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT03185754?

Interventions in NCT03185754: Sublobar resection, lobectomy.

What condition does NCT03185754 study?

NCT03185754 studies Lung Cancer, Surgery.

Is NCT03185754 still recruiting?

NCT03185754 is currently status unknown. Last updated 5 November 2020.

Last reviewed 2020-11-05 · How we verify

NCT03185754

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Sublobar Resection and Lobectomy to Treat Lung Cancer

Status unknown NA Last updated 5 November 2020

What this trial tests

NA trial testing Sublobar resection in Lung Cancer in 600 participants. Status unknown.

Timeline

12 June 2013

Primary endpoint
15 November 2020

31 December 2023

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	600
Start date	12 June 2013
Primary completion	15 November 2020
Estimated completion	31 December 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Sublobar resection
lobectomy

Conditions studied

Lung Cancer — all drugs for Lung Cancer →
Surgery — all drugs for Surgery →

Sponsor

National Taiwan University Hospital

Who can join

Adults 30 to 80, any sex, with Lung Cancer or Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multi-center prospective randomized trial in Taiwan to investigate whether sublobar resection, as compared to lobectomy, can offer equivalent clinical results to treat early non-small cell lung cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Function-preserving radical surgery for early-stage non-small cell lung cancer: A review of limited resection approaches.
Ohtaki Y, Aokage K, Miyoshi T, Tane K, et al · · 2026 · PMID 41642077 · DOI 10.1093/jjco/hyag013

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03185754 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 5 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03185754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing